British coronavirus vaccine starts human trials in 10,000 sample
The move to human trials has been fast-tracked as at least eight firms, according to the WHO, are working to find a reliable and safe vaccine
22 May 2020 - 14:45
Frankfurt — Oxford University and AstraZeneca are recruiting about 10,000 adults and children in Britain for trials of an experimental coronavirus vaccine, a day after receiving US backing worth up to $1.2bn.
Institutions across Britain have begun enrolling up to 10,260 adults and children to see how well the human immune system responds to the vaccine and how safe it is, the university said...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.